Book Chapters

  1. Couvreur P., Roblot-Treupel L., Puisieux F., Fattal E., Andremont A., Chiannilkulchai N., Brasseur F. Improved efficacy and safety by incorporation into minivesicles and miniparticles. In Topics in Pharmaceuticals Sciences, Eds. Breimer D.D., Crommelin D.J.A. & Midha K.K., Elsevier Publishers, 651-659, 1989.
  2. Fattal E., Balland O., Alphandary H., Pecquet S., Puisieux F., Couvreur P., Andremont A. Colloidal drug carriers of antibiotics as an alternative approach for the treatment of intracellular infections. In Antimicrobial agents and intracellular pathogens, Raoult D. Ed, CRC press, Boca Raton, Florida, 63-72, 1993.
  3. Couvreur P., Vauthier C., Fattal E., Dubernet C., Alphandary H. Drug targeting via colloidal particles. In Topics in Pharmaceuticals Sciences, Eds. Crommelin D.J.A., Midha K.K., Nagai T., Elsevier Publishers, 335-350, 1993.
  4. Puisieux F., Barratt G., Benita S., Couarraze G., Couvreur P., Devissaguet J.P., Dubernet C., Fattal E., Fessi H., Vauthier C. Polymeric micro and nanoparticles as drug carriers. In Polymeric Materials for biomedical applications, Dumitriu S. & Szycher M Eds. Marcel Dekker Inc. New York, 749-794, 1993.
  5. Nir S., Fattal E., Parente R.A., Nieva J.L., Wilschut J., Szoka Jr. F.C. Interactions of peptides with phospholipid vesicles: Fusion, leakage and flip-flop. In: «Trafficking of intracellular membranes. From Molecular Sorting to Membrane Fusion”. NATO ASI Series, subseries “Cell biology”. Pedroso De Lima M.C., Duzgunes N., Hoekstra D. (Eds). Springer Verlag, Heidelberg, 71-96, 1995.
  6. Fattal E., Ramaldes G., Ollivon M. Oral delivery of vaccines by means of liposomes. In Liposomes, new systems and new trends in their applications. Puisieux F., Delattre J., Couvreur P., Devissaguet J.P. (Eds). Edition de Santé – PARIS, 693-710, 1995.
  7. Delattre J., Lahiani M., Fattal E., Couvreur P., Rossignol P., Puisieux F., Auger J., Jouannet P. Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP). In vitro and In vivo studies. In Liposomes, new systems and new trends in their applications. Puisieux F., Delattre J., Couvreur P., Devissaguet J.P. (Eds). Edition de Santé – PARIS, 523-541, 1995.
  8. Fattal E., Peracchia M.T., Couvreur P. Poly(alkylcyanoacrylates) In Handbook of Polymer. Domb A.J., Kost J., Wiseman D.M. (Eds). Hardwood academic publishers, 183-202, 1997.
  9. Fattal E., Blanco-Prieto M. J., Leo E., Puisieux F., Couvreur P Design of nanoparticles for vaccine delivery In Antigen delivery systems. Gander B., Merkle H., Corradin G. Eds. Hardwood academic publishers, 139-157, (1997).
  10. Bochot A., Fattal E., Couvreur P. Design of a new eye delivery system for oligonucleotide based on a liposomal dispersion in a gel. In Future strategies for drug delivery with particulate systems, Diederichs J.E., Muller R. Eds, Medpharm Scientific publisher, 5-10, 1998).
  11. Aynie I., Vauthier C., Fattal E., Foulquier M., Couvreur P. Alginate nanoparticles as a novel carrier for antisense oligonucleotides. In Future strategies for drug delivery with particulate sytems, Diederichs J.E., Muller R. Eds, Medpharm Scientific publisher, 11-15, 1998.
  12. Blanco M.J., Fattal E., Puisieux F., Couvreur P. Multiple emulsion as a common step for the design of polymeric microparticles. In Multiple emulsions, Seiller M. and Grossiord J.L. Eds, Edition de Santé – PARIS, 397-435, 1998.
  13. Couvreur P., Peracchia M.T., Desmaele D., Vauthier C., Labarre D., Fattal E., D’angelo J. Development of novel technologies for the synthesis of biodegradable pegylated nanoparticle. In Targeting of drugs 6: Strategies for stealth therapeutic systems, Gregoriadis G. Eds, Nato ASI Series, 225-239, 1998.
  14. Fattal E., Quaglia F., Gupta P., Brazeau G. Biodegradable microparticles for the development of less-painful and less-irritating parenterals, in Pain, Irritation and/or muscle damage with injectable products. Gupta P., Brazeau G. Eds, Interpharm Press, Denver, USA, 355-378 1999.
  15. Fattal E., Couvreur P. Polymeric nanoparticles and microparticles as carriers for antisense oligonucleotides, in Pharmaceutical aspects of oligonucleotides, Couvreur P., Malvy C. Eds, Taylor and Francis, UK, 128-145, 2000.
  16. Couvreur P., Malvy C., Dubernet C., Fattal E. Liposomes for the delivery of oligonucleotides, in Pharmaceutical aspects of oligonucleotides, Couvreur P., Malvy C. Eds, Taylor and Francis, UK I, 146-171, 2000.
  17. Dubernet C., Fattal E., Couvreur P. Nanoparticulate controlled release systems for cancer therapy. In Handbook of Pharmaceutical Controlled Release Technology. Marcel Dekker Inc., Basel, Switzerland, ch 21, pp 413-430, 2000.
  18. Barratt G., Couarraze G., Couvreur P., Dubernet C., Fattal E., Gref R., Labarre D., Legrand P., Ponchel G., Vauthier C. Polymeric micro and nanoparticles as drug carriers In Polymeric Materials for biomedical applications, Dumitriu S. & Szycher M Eds. Marcel Dekker Inc. New York, 753-782, 2001.
  19. Fattal E., Vauthier C Nanoparticles as drug delivery systems. In Encyclopedia of Pharmaceutical Technology, Swarbrick J. & Boylan J. C. eds, Marcel Dekker Inc., Basel, Switzerland 1874-1892, 2002.
  20. Vauthier C., Fattal E., Labarre D. From polymer chemistry and physico-chemistry to nanoparticulate drug carrier design and applications. In Tissue engineering and novel delivery systems. Yaszemski M.J., Trantolo D.J., Lewandroski K.U., Hasirci V., Altobelli D.E., Wised D.L. Ed, Marcel Dekker Inc New York Basel, 563-598, 2004.
  21. Fattal E., Couvreur P. Poly(alkylcyanoacrylate) nanoparticles for nucleic acid delivery. In Polymeric Gene delivery, Amiji M.M Ed, CRC Press, 387-398, 2005.
  22. Maillard S., Fattal E., Marsaud V., Sola B., Renoir J.M. Colloidal systems for the delivery of anticancer agents in breast cancer and multiple myeloma In Nanomaterials for Cancer Therapy Kumar, Challa S. S. R. Ed WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 371-391, 2006.
  23. Fattal E., Andrieux K., Barratt G., Couvreur P., Labarre D., Ponchel G., Vauthier C. Recent Advances in Polyalkylcyanoacrylate Nanoparticles for Drug Delivery; In Nanoparticles for Pharmaceutical applications. Domb A.J., Tabata Y., Kumar R. Faber Eds, American Scientific Publishers, Stevenson Ranch, Ca, USA, 213-232, 2007.
  24. Fattal E., De Rosa G. Polymeric nano and microparticles for the delivery of antisense oligonucleotides and siRNA, Smyth Templeton N. Ed, CRC Press, Boca Raton, USA, 599-615, 2009.
  25. Claude J.-R. and Members of Afssaps Working Party Recommendations for Toxicological Evaluation of Nanoparticle Medicinal Products International Pharmaceutical Product Registration Anthony C. Cartwrightand Brian R. Matthews Eds, 755, 2009.
  26. Fattal E., Hillaireau H., Mura S., Nicolas J., Tsapis N. Targeted delivery using biodegradable polymeric nanoparticles. In Fundamentals and Applications of Controlled Release Drug Delivery Advances Book Series: Delivery Science and Technology. Editors: Siepmann J., Siegel R.A., Rathbone M.J., Springer, 255-288, 2012.
  27. Vauthier C., Couvreur P., Fattal E. Nanomaterials: Applications in Drug Delivery In Nanomaterials: A Danger or a Promise? A Chemical and Biological Perspective. Editors: Brayner R., Fiévet F., Coradin T., Springer, 131-151, 2013.
  28. Grabowski N., Hillaireau H., Vergnaud J., Fattal E., Evaluation of lung toxicity of nanoparticles, In Targeted Drug Delivery: Concepts and Design; Devarajan P. V., Jain S., Springer, 689-732, 2015.
  29. Mota A.H., Sousa A., Figueira M., Amaral M., Sousa B., João Rocha, Elias Fattal, António José Almeida, Catarina Pinto Reis, Chapter 19 – Natural-based consumer health nanoproducts: medicines, cosmetics, and food supplements, Editor(s): Chaudhery Mustansar Hussain, In Micro and Nano Technologies, Handbook of Functionalized Nanomaterials for Industrial Applications, Elsevier, 2020, Pages 527-578,